subject: Takeda Pharmaceutical Company Limited Swot Profile---aarkstore Enterprise Market Research Aggregatio [print this page] Summary Summary
Takeda Pharmaceutical Company Limited SWOT Profile is a comprehensive business, functional and strategic analysis of Takeda Pharmaceutical Company Limited. The profile delves into the operations of the company to present an in-depth analysis of the various aspects related to its business. It analyzes the companys business structure, operations, major products and services, prospects, locations and subsidiaries, executive biographies and key competitors. The hallmark of the profile is the detailed strategic analysis of the company. This highlights and presents an unbiased view of its key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by understanding your partners, customers and competitors better.
Takeda Pharmaceutical Company Limited (Takeda) is a global pharmaceutical company mainly focused on the research and development of ethical drugs for the treatment of cancer, diabetes and peptic ulcers. The company is also engaged in manufacturing and marketing of photographic chemicals, inorganic chemicals, vitamin bulks, health foods, beverages, test reagents & clinical diagnostics.
Key Recent Developments
Apr 19, 2010: Takeda Pharma Gets Japanese Approval For Five New Products
Apr 19, 2010: FDA Considering To Halt GSK Avandia Safety Study
Apr 13, 2010: Metabolex Enters Into Research Collaboration With Takeda San Francisco
Scope
- Examines key information about company for business intelligence.
- The companys core strengths and weaknesses and areas of development or decline are analyzed and presented objectively. Business, strategic and operational aspects are taken into account.
- Opportunities available to the company are sized up and its growth potential assessed. Competitive and/or technological threats are highlighted.
- The profile contains valuable and critical company information business structure and operations, the company history, major products and services, prospects, key competitors, key employees, executive biographies, important locations and subsidiaries.
- The profile provides detailed financial ratios for the past five years as well as interim ratios for the last five interim periods for major public companies.
- Financial ratios presented for major public companies include revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
